These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 8339376)
21. [Bone marrow transplantation versus maintenance chemotherapy for adult acute leukemia in first remission]. Suzuki R; Iida H; Taji H; Murata M; Sugihara T; Minami S; Kodera Y Rinsho Ketsueki; 1996 Dec; 37(12):1362-70. PubMed ID: 8997123 [TBL] [Abstract][Full Text] [Related]
22. Factors affecting engraftment and hematopoietic recovery after unpurged autografting in acute leukemia. Mehta J; Powles R; Horton C; Treleaven J; Singhal S Bone Marrow Transplant; 1996 Aug; 18(2):319-24. PubMed ID: 8864441 [TBL] [Abstract][Full Text] [Related]
23. Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia. van Agthoven M; Groot MT; Verdonck LF; Löwenberg B; Schattenberg AV; Oudshoorn M; Hagenbeek A; Cornelissen JJ; Uyl-de Groot CA; Willemze R Bone Marrow Transplant; 2002 Aug; 30(4):243-51. PubMed ID: 12203141 [TBL] [Abstract][Full Text] [Related]
24. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients. Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553 [TBL] [Abstract][Full Text] [Related]
25. Bone marrow transplantation for therapy-induced acute myeloid leukemia in children with previous lymphoid malignancies. Hale GA; Heslop HE; Bowman LC; Rochester RA; Pui CH; Brenner MK; Krance RA Bone Marrow Transplant; 1999 Oct; 24(7):735-9. PubMed ID: 10516676 [TBL] [Abstract][Full Text] [Related]
26. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia]. Huang H; Lin M; Meng H Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883 [TBL] [Abstract][Full Text] [Related]
27. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma. Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450 [TBL] [Abstract][Full Text] [Related]
28. Is veno-occlusive disease incidence influenced by the total-body irradiation technique? Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791 [TBL] [Abstract][Full Text] [Related]
29. Myeloablative therapy and bone marrow transplantation in Jehovah's Witnesses with malignancies: single center experience. Mazza P; Prudenzano A; Amurri B; Palazzo G; Pisapia G; Stani L; Pricolo G Bone Marrow Transplant; 2003 Aug; 32(4):433-6. PubMed ID: 12900781 [TBL] [Abstract][Full Text] [Related]
31. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen. Matsuyama T; Kojima S; Kato K Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791 [TBL] [Abstract][Full Text] [Related]
32. Importance of bone marrow cell dose in bone marrow transplantation. Paulin T Clin Transplant; 1992 Feb; 6(1):48-54. PubMed ID: 10150090 [TBL] [Abstract][Full Text] [Related]
33. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia. Betticher DC; Huxol H; Müller R; Speck B; Nissen C Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233 [TBL] [Abstract][Full Text] [Related]
34. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit. Thakkar SG; Fu AZ; Sweetenham JW; Mciver ZA; Mohan SR; Ramsingh G; Advani AS; Sobecks R; Rybicki L; Kalaycio M; Sekeres MA Cancer; 2008 May; 112(10):2233-40. PubMed ID: 18348307 [TBL] [Abstract][Full Text] [Related]
35. [Sophie receives new bone marrow from her brother]. Lanouette M; St-Jacques A Nurs Que; 1990; 10(2):48-54. PubMed ID: 2320335 [No Abstract] [Full Text] [Related]
36. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia]. Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472 [TBL] [Abstract][Full Text] [Related]
37. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up. Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531 [TBL] [Abstract][Full Text] [Related]
39. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome. Rubin CM; Mick R; Johnson FL Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614 [TBL] [Abstract][Full Text] [Related]
40. Autologous bone marrow transplantation in adult acute lymphoblastic leukaemia. Wojnar J; Hołowiecki J; Krawczyk-Kuliś M; Markiewicz M; Wojciechowska M; Kyrcz-Krzemień S; Kopera M; Kruzel T; Kachel L Transplant Proc; 1996 Dec; 28(6):3518-21. PubMed ID: 8962368 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]